Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors.
Villalona-Calero MA, Diaz JP, Duan W, Diaz Z, Schroeder ED, Aparo S, Gatcliffe T, Albrecht F, Venkatappa S, Guardiola V, Garrido S, Rubens M, DeZarraga F, Vuong H.
Villalona-Calero MA, et al. Among authors: gatcliffe t.
Biomark Res. 2022 Jun 3;10(1):39. doi: 10.1186/s40364-022-00386-0.
Biomark Res. 2022.
PMID: 35658948
Free PMC article.